Watch "Pink & Blue: Colors of Hereditary Cancer"

Friday, January 27, 2017

UCSF Center for BRCA Research presents screening of Pink & Blue: Colors of Hereditary Cancer

Community Event: Film Screening and Panel on Hereditary Cancer

On February 13, 2017, the UCSF Center for BRCA Research presents a film screening of Pink & Blue: Colors of Hereditary Cancer, a documentary chronicling the effects of BRCA on men and women. Prior to the film, join us for a reception and special panel of hereditary cancer experts featuring Dr. Alan Ashworth, who appears in the film and is known for his research contributions to BRCA and BRCA-related cancers.

FILM SCREENING AND PANEL 
PINK & BLUE: COLORS OF HEREDITARY CANCER
Monday, February 13, 2017  |  
6:00 pm - 9:00 pm

REGISTER

 
UCSF Mission Bay, Byers Auditorium
Genentech Hall, 600 16th Street
San Francisco, CA 94158


We welcome patients, former patients, survivors, caregivers, as well as local community members! There is no cost to attend, but please take a moment to register for the event.
About the Film

Pink & Blue: Colors of Hereditary Cancer is an emotional journey that takes us through the lives of women and men who are dealing with genetic mutations (BRCA 1 and 2) and their related hereditary cancers.

We meet the doctors and their patients who make the tough decisions on whether to have preventative surgeries or not. Director Alan M. Blassberg tells the story of how this disease ripped his family apart and what he must face as a BRCA 2 positive male. The film highlights the message that men carry this mutation half the time and that this lack of information is deadly. There is a higher percentage of MEN dying from breast cancer than women.
World-renowned specialists from the UCSF Helen Diller Family Comprehensive Cancer Center (Alan Ashworth, PhD, FRS), Cedars-Sinai, Basser Center for BRCA, and the Pink Lotus Breast Center (including Dr. Kristi Funk, MD, who is Angelina Jolie's surgeon) weigh in with the latest information on BRCA mutations, breast cancer, and the various changes that can be addressed for male patients.